Clinical Trial Update: A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating guselkumab is being studied in Indian participants for psoriatic arthritis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Guselkumab (guselkumab)

Snippet

Sponsor: Johnson & Johnson Private Limited | Conditions: Arthritis, Psoriatic | Phase 4 | Status: RECRUITING